 |
Chief Executive Officer
Charles L. M. Dunlop
Chief Scientific Officer
Anja Kammesheidt, PhD
Medical Director
James A. Thompson, MD, PhD Headquarters
Ambry Genetics
100 Columbia #200
Aliso Viejo, CA 92656
949-900-5500 TEL
949-900-5501 FAX
Media Relations
Bruce S. Gardner
949-900-5509
bgardner@ambrygen.com
TIMELINE
2000
Ambry Genetics founded to
provide cost effective, comprehensive
gene testing
2002
Launched first product for comprehensive
Cystic Fibrosis Assay
2003
Achieved profitability
2003
Launched
Chronic Pancreatitis Assay
2004
Secured first licensing deal for novel genes
2005
Launched innovative 508 FIRST
Cystic Fibrosis testing pathway
2006
Launched Alpha-1-Antitrypsin
Deficiency Assay |
|
 |
|
Business |
 PROVIDING
ANSWERS WITH COMPREHENSIVE
GENE SEQUENCE ANALYSIS
Ambry Genetics is a worldwide leader in specialized genetic
testing. The Company’s advancements in Cystic Fibrosis,
chronic and hereditary pancreatitis, alpha-1-antitrypsin deficiency,
and other severe pulmonary diseases are providing precise, cost-effective
methods to aid in disease definition and early, more accurate
diagnosis.
|
|
|
Technology |
The proprietary Ambry Test™ combines scanning
and sequencing technologies to analyze a gene’s entire
coding region plus surrounding critical introns. Capable of
identifying approximately 99% of all disease-causing mutations
of the CFTR gene, the company’s reputable Cystic Fibrosis
test has an unrivaled detection rate across all ethnic groups.
The Company also created the world’s first and only comprehensive
genetic test for three principal genes (PRSS1, SPINK1 and CFTR)
associated with Chronic and Hereditary Pancreatitis. Ambry Genetics’
most recent developments focus on diagnosis of pulmonary conditions,
including Alpha-1-Antitrypsin Deficiency, Surfactant Protein
B Deficiency, and Surfactant Protein C Deficiency, which is
associated with pulmonary fibrosis and other interstitial lung
diseases.
|
|
|
Year Founded |
2000
|
|
|
Lead Product |
The proprietary Ambry Test™ combines
scanning and sequencing technologies to analyze a gene’s
entire coding region plus surrounding critical introns.
|
|
|
Financials |
Ambry Genetics Corp. is a privately held
company.
|
|
|
Corporate Headquarters |
Ambry Genetics
100 Columbia #200
Aliso Viejo, CA 92656
Ambry
Genetics Fact Sheet
(Abobe PDF document)
|
|
